HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(((((4- hydroxy- 4,4- diphosphonobutyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethanethiolate)oxorhenium(V)

Also Known As:

186Re-MAG3-HBP

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - (((((4-hydroxy-4,4-diphosphonobutyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethanethiolate)oxorhenium(V): 1
- Organometallic Compounds: 64
  - (((((4-hydroxy-4,4-diphosphonobutyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethyl)carbamoylmethanethiolate)oxorhenium(V): 1

Experts

1.	Arano, Yasushi: 1 article (07/2005)
2.	Hanaoka, Hirofumi: 1 article (07/2005)
3.	Hashimoto, Kazuyuki: 1 article (07/2005)
4.	Ishino, Seigo: 1 article (07/2005)
5.	Mukai, Takahiro: 1 article (07/2005)
6.	Nishimura, Hiroshi: 1 article (07/2005)
7.	Ogawa, Kazuma: 1 article (07/2005)
8.	Ono, Masahiro: 1 article (07/2005)
9.	Saji, Hideo: 1 article (07/2005)

Related Diseases

1.	Pain (Aches) 07/01/2005 - "In conclusion, 186Re-MAG3-HBP is expected to be a useful radiopharmaceutical for the palliation of metastatic bone pain."

Related Drugs and Biologics

1.	Radiopharmaceuticals